In conclusion, these results indicate that the GS composition is modulated in iCCA and highlight a novel role of the synergy obtained by merging GD3S expression with ganglioside GD2 as a regulator of the biology of iCCA and of cancer stemness in this tumour. Here, PRRT2 is linked to neoplasm.